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Functionally related neurons assemble into connected networks that process and
transmit electrochemical information. To do this in a coordinated manner, the number
and strength of synaptic connections is tightly regulated. Synapse function relies on
the microtubule (MT) cytoskeleton, the dynamics of which are in turn controlled by a
plethora of MT-associated proteins, including the MT-stabilizing protein Tau. Although
mutations in the Tau-encodingMAPT gene underlie a set of neurodegenerative disorders,
termed tauopathies, the exact contribution of MT dynamics and the perturbation thereof
to neuronal network connectivity has not yet been scrutinized. Therefore, we investigated
the impact of targeted perturbations of MT stability on morphological (e.g., neurite- and
synapse density) and functional (e.g., synchronous calcium bursting) correlates of
connectivity in networks of primary hippocampal neurons. We found that treatment
with MT-stabilizing or -destabilizing compounds impaired morphofunctional connectivity
in a reversible manner. We also discovered that overexpression of MAPT induced
significant connectivity defects, which were accompanied by alterations in MT dynamics
and increased resistance to pharmacological MT depolymerization. Overexpression of
a MAPT variant harboring the P301L point mutation in the MT-binding domain did far
less, directly linking neuronal connectivity with Tau’s MT binding affinity. Our results show
that MT stability is a vulnerable node in tauopathies and that its precise pharmacological
tuning may positively affect neuronal network connectivity. However, a critical balance in
MT turnover causes it to be a difficult therapeutic target with a narrow operating window.
Keywords: microtubule, primary hippocampal neuron, neuronal network, synapse, P301L, Tau aggregation,
high-content microscopy, live cell imaging
INTRODUCTION
Hippocampal neurons exhibit an extraordinary morphology with long axons and complex
dendritic trees to exert their function as information integrators and transmitters. Arguably, the
most important cytoskeletal components that support this architecture are the microtubules (MTs).
MTs are polarized multimers of α- and β-tubulin heterodimers which are not rigid but show phases
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of growing and shrinking, a process known as dynamic
instability. While the bulk of neuronal MTs is more stable
(average growth at plus end v+ = 0.2 µm/s) than MTs of
dividing cells (v+ = 0.5 µm/s; Stepanova et al., 2003), there
is also an important fraction of shorter, unstable MTs. Even
within the same MT, domains can be discriminated that show
differential stability, composition and interaction with MT-
associated protein (Baas et al., 2016). MT plus-end tracking
proteins (+TIPs) interact with numerous cytoplasmic signaling
proteins to regulate MT dynamics (Dent and Baas, 2014). Other
mechanisms of regulation include tubulin post-translational
modifications, binding and bundling of individual MTs by MT-
associated proteins, and the intrinsic polarity of MT arrays. The
latter is very different in axons than it is in dendrites (Wloga and
Gaertig, 2011; Kapitein and Hoogenraad, 2015).
Motor-dependent trafficking of mRNA, (antero- and
retrograde signaling) proteins, synaptic vesicle precursors
and organelles along MTs is crucial for synapse formation,
elimination and plasticity (van den Berg and Hoogenraad, 2012).
While stable MTs provide structural support, and facilitate
cargo transport along the neurites, a subset of unstable MTs is
directly involved in local signaling at the synapse (Gardiner et al.,
2011; Dent, 2017). More specifically, dynamic MTs physically
enter dendritic spines in response to synaptic NMDA receptor
activity and modulate spine morphology via interaction with
F-actin (Jaworski et al., 2009; Merriam et al., 2013). Furthermore,
proteins such as Ca2+/calmodulin-dependent protein kinase II
and Tau can translocate between dendritic MTs and adjacent
spines in response to synaptic activity (Lemieux et al., 2012;
Frandemiche et al., 2014; McVicker et al., 2015).
Given their prominent role in synapse function, it is
not surprising that dysregulation of neuronal MT dynamics
is associated with mental and cognitive symptoms (Zempel
and Mandelkow, 2015; Marchisella et al., 2016). Many drugs
used in anti-cancer treatment exert their cytostatic effect via
hyper- (e.g., paclitaxel) or destabilization (e.g., nocodazole)
of MTs during mitotic spindle formation. Cancer patients
receiving paclitaxel not only suffer from peripheral neuropathy
as a side effect, but also experience cognitive problems that
may persist after cessation of the therapy (Wefel et al.,
2010; Jaggi and Singh, 2012; Gornstein and Schwarz, 2014).
Furthermore, it is also known that MT dysregulation contributes
to the reduced dendritic complexity and synaptic density in
central neurons of patients suffering from mood disorders
and schizophrenia (Andrieux et al., 2006; Marchisella et al.,
2016). But, perhaps the best characterized link between MT
dysregulation and impaired neuronal connectivity can be found
in so-called tauopathies. Tau is one of the MT-stabilizing
proteins (Weingarten et al., 1975; Cleveland et al., 1977)
with a role in axon elongation (Sayas et al., 2015), release
of cargo from motor proteins near the synapse (Medina
et al., 2016), and long-term depression of synaptic transmission
(Regan et al., 2015). In tauopathies such as frontotemporal
dementia and Alzheimer’s disease (AD), mutations are frequently
Abbreviations: MT, microtubule; PI, propidium iodide; PCC, Pearson’s
Correlation Coefficient.
found in MAPT, the gene encoding Tau. These mutations are
often associated with increased levels of Tau phosphorylation
and decreased MT affinity (Hong et al., 1998; Dayanandan
et al., 1999; Barghorn et al., 2000; von Bergen et al.,
2001).
Alterations in MT stability have been reported in several
animal models for CNS disorders and pharmacological MT
stabilization was found to alleviate behavioral symptoms in
some of these models (Andrieux et al., 2006; Barten et al.,
2012; Zhang et al., 2012; Vaisburd et al., 2015). However, the
relationship between MT stability and synaptic connectivity has
not yet been scrutinized at the cellular level. We previously
showed that primary hippocampal cultures form spontaneously
active, synaptically connected neuronal networks and hence
represent a valid in vitro model for studying morphofunctional
features of neuronal connectivity (Cornelissen et al., 2013;
Verstraelen et al., 2014; Detrez et al., 2016). Here, we exploit
this model to gain further insight into the role of MT dynamics
in neuronal connectivity using targeted pharmacological and
genetic perturbations.
MATERIALS AND METHODS
Preparation of Primary Hippocampal
Cultures
This study was carried out in accordance with the
recommendations of the ethical committee for animal
experimentation of the University of Antwerp (approved
ethical files 2013-46 and 2015-54).
Hippocampi were dissected from WT E18 C57Bl6 mouse
embryos inHepes(7mM)-bufferedHanks Balanced Salt Solution,
followed by trypsin digestion (0.05%; 10 min; 37◦C) and
mechanical dissociation by trituration through 2 fire-polished
glass pipettes with decreasing diameter. After centrifugation
(5 min at 200 g), the cell pellet was resuspended in Minimal
Essential Medium supplemented with 10% heat-inactivated
normal horse serum and 30 mM glucose. Cells were plated in
Poly-D-Lysin-coated 96-well plates (Greiner Cell coat, µClear),
at 45,000 cells/cm2, and kept in a humidified CO2 incubator
(37◦C; 5% CO2). After 4 h, the medium was replaced with
B27 supplemented Neurobasal medium, containing Sodium
Pyruvate (1 mM), Glutamax (2 mM) and glucose (30 mM). To
suppress proliferation of non-neuronal cells, arabinosylcytosine
was added in 50 µl Neurobasal-B27 medium at the third day
after plating. The cultures were grown without any further
medium replacement until the time of analysis, with a minimum
of 7 days in vitro (DIV) to ascertain a sufficiently connected
network (Figure 1). Cell culture supplies were purchased from
ThermoFisher.
Pharmacology
Drugs were purchased from Sigma-Aldrich or obtained via an
in-house J&J compound library. Paclitaxel or nocodazole (0.1–
100 nM) was added at the fourth day in vitro (DIV). Effects
were evaluated at 7 DIV without medium replacement. For acute
nocodazole treatment, 1 µMwas added at 7 DIV and effects were
assessed after 2, 4, or 8 h. For rescue experiments, nocodazole
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FIGURE 1 | General workflow of experiments on primary hippocampal neurons. Hippocampi of E18 embryos from the same mother mouse were pooled, dissociated,
and seeded in 96-well plates. Sacrificing one mother mouse with on average 9 embryos yielded 300–350 wells (15,000 cells/well). The week-separated dissection of
one mother mouse was considered a biological replicate. Per treatment condition, there were 2–6 wells from 2–3 biological replicates (see also Supplemental Table 1).
Though treatments (pharmacological or MAPT overexpression) were often started earlier, analyses were carried out on mature neuronal networks of 7-22 DIV. After
fluorescent labeling, 3D (XYZ) images were automatically acquired at different positions (fields, F), and in different channels (C), thus yielding 5D datasets per well
(XYZCF). Multiple features were extracted and averaged per well (e.g., when 16 fields were acquired per well) before proceeding to statistical analysis.
(1 µM) was added, followed after 2 h by paclitaxel (100 nM)
or epothilone D (100 nM). Fixation and calcium imaging were
carried out 4 h after initial nocodazole treatment. As such, the
cells were exposed to nocodazole alone for 2 h, followed by
a 2 h period of the nocodazole/MT stabilizer combination. As
control, DMSO was added two times, upon nocodazole as well
as MT stabilizer treatment. For evaluation of the resistance to
nocodazole-induced depolymerization, cultures were pre-treated
with 10 nM paclitaxel or transduced with MAPT(-P301L)-eGFP
at 3 DIV. At 10 DIV, cultures were treated with 1 µMnocodazole
for 4 h and then fixed for immunocytochemistry.
Viral Transduction and Treatment with K18
fibrils
AAV6 particles for the neuronal-specific (hSyn1 promoter)
overexpression of human 4R-MAPT-eGFP, 4R-MAPT(P301L)-
eGFP, and eGFP (as AAV control) were produced as described
before (Taschenberger et al., 2013; Calafate et al., 2015) and were
administered at 3 DIV at MOI 100, unless indicated otherwise.
Both the MAPT and MAPT-P301L overexpression constructs
used in this study coded for 4-repeat Tau, which is the form that
has the highest affinity for MTs (Dayanandan et al., 1999). To
produce K18 fibrils, monomeric Tau K18-P301L (40 µM) was
incubated for 48–72 h at 37◦C in the presence of the polyanion
heparin (40 µM), DTT (2 mM) and sodium acetate buffer (100
mM; pH 7.0). The solution was centrifuged (100,000 g, 1 h, 4◦C)
and the pellet was resuspended in sodium acetate buffer and
sonicated before use. At 6 DIV, Tau aggregation was induced by
adding the K18 fibrils (25 nM; Guo and Lee, 2013) to the culture
medium.
Staining and Immunocytochemistry
For cytotoxicity measurement, live 7 DIV cultures were
incubated with 2.5 µg/ml propidium iodide (PI, Sigma-Aldrich)
and 10 µg/ml of the membrane-permeable Hoechst 33342
(Sigma-Aldrich) for 30 min at 37◦C and 5% CO2, without
removal of the culture medium. For immunocytochemistry,
paraformaldehyde-fixed cultures (2%, 20 min, RT) were
permeabilized with 1% Triton X-100 in blocking buffer (0.1%
bovine serum albumin and 10% normal horse serum in PBS)
for 10 min, followed by a 4-h incubation with the primary
antibodies (Table 1) at RT in blocking buffer. After washing with
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TABLE 1 | Primary and secondary antibodies for immunocytochemistry.
Primary antibodies
β-III-tubulin Rabbit Polyclonal Covance PRB-435P 1/2,000
MAP2 Chicken Polyclonal abcam ab5392 1/5,000
Synaptophysin-I Guinea Pig Polyclonal Synaptic Systems 101 004 1/1,000
Acetylated α-tubulin Mouse monoclonal Sigma-Aldrich T6793 1/2,000
Total Tau Rabbit Polyclonal Dako A0024 1/2,000
AT8 (hyperphosphorylated Tau) Mouse Monoclonal ThermoFisher MN1020 1/5,000
Secondary antibodies
Donkey-anti-Mouse FITC/Cy5 Jackson 715-095-150 1/1,000
715-175-150
Goat-anti-Rabbit FITC/Cy3 Jackson 111-095-047 1/4,000
Fab fragments 111-165-047
Donkey-anti-Guinea Pig Cy3 Jackson 706-165-148 1/1,000
PBS, secondary antibodies (Table 1) were added for 2 h. Finally,
DAPI was applied to the cultures for 10 min at a concentration
of 2.5 µg/ml, followed by a PBS wash. To label fibrillar Tau,
cultures were stained with pentameric formyl thiophene acetic
acid (pFTAA; 1 µM, 2 h) (Aslund et al., 2009; Brelstaff et al.,
2015).
Microscopy
For cytotoxicity measurements, images were acquired on a BD
pathway 435 Bioimager (20X, NA 0.75, Becton Dickinson).
To minimize imaging time, these images were acquired in
non-confocal mode (1 Z-plane). All images on fixed cultures
were acquired in confocal mode with a spinning disk confocal
microscope (40X, NA 0.95, UltraVIEW VoX, PerkinElmer) or
in high-throughput mode on an Opera Phenix High Content
Screening System (40XW, NA 1.2, PerkinElmer). Per well, 16
frames (4 × 4) were acquired with an inter-frame gap of 500
µm. Per frame, up to 4-channel images (405, 488, 561, and
640 nm excitation) were acquired in at least 6 axial positions
separated by a 1 µm spacing, thus yielding 5-dimensional image
data sets (XYZCF; Figure 1). Different fluorescence channels
were separated using standard excitation/emission filters and
dichroicmirrors. In case of confocal imaging,maximum intensity
projections were used for downstream image analysis.
High-Content Image Analysis
High-content image analysis scripts for immunostained neuronal
networks were developed for FIJI image analysis freeware
(Schindelin et al., 2012). For all workflows, images were pre-
processed using a rolling ball background subtraction to correct
for illumination heterogeneity. To analyze cytotoxicity, images
of Hoechst 33342 counterstained cells were first smoothed by
Gaussian blurring (radius 1.75 µm) and segmented using a
fixed threshold. Neighboring nuclei were separated by watershed
segmentation and debris was removed by size filtering of the
segmented objects (minimum size of 90 µm2). This resulted
in a set of regions of interest (ROIs) corresponding to the
total number of nuclei. Dead cells were then identified as ROIs
for which the average intensity in the PI channel exceeded a
fixed intensity threshold. To measure neurite density after β-
III-tubulin or MAP2 immunolabeling, a multi-tier approach
was employed, based on MorphoNeuroNet (Pani et al., 2014;
Detrez et al., 2016) (the updated script, Neuronmetrics.ijm,
is available upon request). In brief, the high intensity parts
of the image were extracted by an automated thresholding
procedure (Isodata algorithm) yielding a first mask. To also
include the finer, low-intensity parts of the cytoskeletal network,
a second mask was established by local contrast enhancement
(block size 1.8 µm, slope 3) followed by Laplacian edge
enhancement. Both masks were combined into a single network
ROI of which the surface was measured. To quantify tubulin
acetylation, the intensity ratio of acetylated α- over β-III-
tubulin was measured inside the network ROI. The intensity
ratio of AT8 over total Tau was measured in a similar way.
To assess the integrity of the MT network, the colocalization
between β-III- and acetylated α-tubulin was quantified in
terms of the Pearson correlation coefficient (Manders et al.,
1993). Fibrillar Tau structures were identified in neurons after
enhancing tube-like structures in the pFTAA channel (Tubeness
plugin, sigma 3), automated thresholding (Triangle algorithm)
and particle analysis (minimum size 15 µm2 and circularity
0.00-0.30). The fibrillary Tau load was expressed as total
area of the segmented particles within the MT mask. To
quantify synaptophysin spots, images were pre-processed by
means of Laplace filtering (smoothing scale 0.35 µm), followed
by automated thresholding (Triangle algorithm), particle size
filtering (minimum size of 0.75 µm2) and spot counting (based
on a pipeline described before; De Vos et al., 2010). Synapse
density was expressed as the number of synaptophysin-I puncta
per µm2 neurite area.
Live Cell Calcium Imaging
For pharmacology experiments, neurons were loaded with 2
µM Fluo-4-AM (ThermoFisher) in Neurobasal B27 medium at
37◦C and 5% CO2. After 30 min, the medium was replaced
with recording medium, containing (in mM): CaCl2 0.9, MgCl2
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0.5, KCl 2.67, NaCl 138, KH2PO4 1.47, Na2HPO4-7H2O 8,
and C6H12O6 10. Because MTs are known to recover from
nocodazole administration upon medium exchange (Baas and
Ahmad, 1992; Jaworski et al., 2009), nocodazole was also
added to the recording medium when appropriate. Cells
were imaged on an inverted dual spinning disk confocal
microscope (UltraVIEW ERS, PerkinElmer) for 260 s, with
a 25X objective lens (NA 0.80) at 2 frames per second. To
distinguish neurons from non-neuronal cells, 30 µM glutamate
was added during the last 20 s of calcium recording (Pickering
et al., 2008). Immediately after the calcium recording, DAPI
was added to allow accurate cell segmentation. For MAPT-
eGFP overexpression experiments, a red genetically encoded
calcium indicator (RGECO; Zhao et al., 2011) was introduced
at 0 DIV via AAV-mediated expression under the synapsin
promoter. Imaging was performed on a spinning disk confocal
microscope (UltraVIEW VoX, PerkinElmer, UK) at 37◦C and
5% CO2 and the same cultures were imaged on different
DIV.
Calcium recordings were analyzed using a home-written
MATLAB script (Cornelissen et al., 2013). In case of Fluo-4
imaging, all cells were segmented based on a nucleus image,
after which traces of the fluorescence intensity over time were
generated. Traces of non-neuronal cells were discarded based on
their response to glutamate. In case of RGECO, the expression
of which was limited to neurons (hSyn1 promoter), ROIs were
manually drawn over neuronal cell bodies. Subsequent signal
analysis returned parameters such as percentage of neurons
that show at least one peak during the recording, frequency of
synchronous calcium bursts and burst correlation, which is the
average of the Pearson’s correlation matrix between all neuron
pairs in the field of view. The original script was also adapted to
allow for simultaneous analysis of neuronal subpopulations (Tau
aggregate-positive vs. -negative) within the same field of view.
EB3 tracking
Cultures were transduced with AAV6 particles for the
overexpression of human 4R-MAPT-eGFP, 4R-MAPT(P301L)-
eGFP, and eGFP (as AAV control) or treated with 10 nM
paclitaxel at 3 DIV. Lentiviral particles encoding an EB3-
RFP fusion protein were added at 5 DIV (LentiBrite EB3-RFP
Lentiviral Biosensor,MerckMillipore,MOI 25). This transfection
protocol resulted in relatively sparse (∼25%) labeling of neurons
and sufficiently isolated axons within the dense neuronal
network. At 10 DIV, 100 nM paclitaxel (4 h) was added to
some of the wells and imaging was performed on a spinning
disk confocal microscope (UltraVIEW VoX, PerkinElmer) at
37◦C and 5% CO2, 60X water immersion objective (NA 1.20).
One frame was recorded every 2 s for 1 min. Image analysis
was carried out in FIJI image analysis freeware (Schindelin
et al., 2012), blinded for treatment conditions. For each well,
at least 7 neurite segments (each >20 µm) were manually
selected and kymographs were generated using the multi-
kymograph plugin (line width 3). The velocity of the EB3
comets was calculated using the “read velocity from tsp” macro
(http://www.embl.de/eamnet/downloads/macros/tsp050706.
txt).
Statistics
The typical workflow of the experiments is shown in Figure 1
and the number of biological (nb) and well (nw) replicates
of each experiment is mentioned in the figure captions and
summarized in Supplemental Table 1. One biological replicate
refers to the dissection of one mother mouse (2–3 biological
replicates per experiment). Biological replicates were separated
in time, meaning that the breeding and housing conditions of
the mice, as well as the cultivation conditions (e.g., media and
well plate batches) were slightly different between biological
replicates. Hippocampi from different E18 embryos from the
same mother mouse were pooled after dissection (6–12 embryos
per mother mouse). As such, sacrificing one mother mouse
with an average of 9 embryos yielded in between 5 and 10
E06 cells. This was sufficient to seed cells in 300–350 96-well
plate wells (2–6 per biological replicate per plate per treatment).
When multiple measurements were done per well (e.g., 16
images were acquired per well in automated microscopy), the
data were first averaged per well before executing statistical
analysis.
Statistical analyses were carried out in SAS JMP Pro
12 software. Shapiro-Wilk W tests were used to check for
normality (Supplemental Table 1). Since the majority of the
data was not normally distributed, non-parametric tests were
performed throughout the paper. Kruskal-Wallis (rank sums)
tests were performed to assess the overall effect across treatments
(Supplemental Table 1). For longitudinal experiments, this
test was performed within each DIV and for studying the
resistance to nocodazole-induced depolymerization, tests were
performed within the DMSO and nocodazole group, separately.
Conditional to the overall Kruskal-Wallis test, post-hoc tests
were performed (∗p < 0.05 and ∗∗p < 0.005; Supplemental
Table 1). A Steel test for comparison with control was used as
the non-parametric alternative for a Dunnett test (Steel, 1959).
For rescue of nocodazole-induced defects, where all pairwise
comparisons were of interest, Dunn all pairs tests for joint
ranks were used as the non-parametric alternative for Bonferroni
tests (Dunn, 1964). The data are represented as bar charts
(mean + standard deviation). No normalization was applied
to suppress the variability between biological replicates, nor
did we use statistical techniques such as Mixed models that
accommodate for this variation. This conservative statistical
testing allowed drawing robust conclusions while keeping the
number of sacrificed animals to a minimum.
RESULTS
Pharmacological Modulation of MT
Stability Impairs Neuronal Network
Connectivity
To assess the impact of MT hyperstabilization on neuronal
network connectivity, a dose-range study of paclitaxel (up to
100 nM) was performed on primary hippocampal cultures,
treated from 4 to 7 DIV. A concentration of 100 nM proved
to be cytotoxic as indicated by a significant increase in
PI-positive cells (Figure 2A), overt neurite pathology (e.g.,
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FIGURE 2 | Pharmacological stabilization of microtubules (MTs) impairs neuronal network connectivity. (A) The percentage of propidium iodide (PI) -positive nuclei
was quantified to measure cytotoxicity. Paclitaxel (4–7 DIV) treatment induced significant toxicity at a concentration of 100 nM (7 DIV; nb = 3, nw = 2). (B) This toxicity
was accompanied by a reduction in neurite density, measured as the area of the neurite marker β-III-tubulin (C) Immunostaining of 7 DIV cultures for β-III-tubulin and
the synapse marker synaptophysin revealed overt neurite pathology and debris (arrowheads) at 100 nM paclitaxel. (D) Quantification of synapse density showed a
significant reduction by 10 and 100 nM paclitaxel. Exposure to 10 nM paclitaxel decreased synapse density while leaving the neurite network largely intact (nb = 3, nw
= 2). (E) Live cell calcium imaging at 7 DIV showed a nearly complete loss of spontaneous activity at 100 nM paclitaxel. (F,G) Sub-toxic paclitaxel doses reduced the
frequency of synchronized bursts, while the synchronicity of the remaining bursts across neurons (Burst correlation; PCC: Pearson’s Correlation Coefficient) was not
affected. The spontaneous activity was lost at 100 nM (ND: not determined since # active neurons/field of view<5; nb = 4, nw = 3). *p < 0.05; **p < 0.005.
dilation, Figures 2B,C), and total absence of calcium oscillations
(Figures 2E–G). A lower, non-toxic concentration of 10 nM
paclitaxel significantly reduced synapse density (as measured by
total number of synaptophysin-positive spots per µm2 neurite,
Figure 2D), while leaving neurite density (as measured by total
ß–tubulin area per field of view, Figure 2B) largely unchanged.
A reduced frequency of synchronized bursts was observed
for all subtoxic concentrations, but the reduction was only
statistically significant for 1 nM paclitaxel (Figure 2F). Burst
correlation, i.e., synchronicity of bursts across neurons, was
not significantly affected (Figure 2G). Thus, the spontaneous
network activity remained synchronous, albeit with longer burst
intervals.
To assess the impact of MT destabilization, we next
examined the effects of nocodazole (Figure 3). Chronic (4-7
DIV) treatment did not induce significant cytotoxicity up to a
concentration of 100 nM (Figure 3A). However, neurite- and
synapse density (Figures 3B,C), as well as the percentage of
active neurons (Figure 3D) and synchronous bursting behavior
(Figures 3E,F), were significantly impaired by 100 nM and, to
a lesser extent, by 10 nM nocodazole. Acute addition of 1 µM
nocodazole at 7 DIV resulted in a progressive thinning of neurites
and the appearance of tubulin patches (Figure 3G, arrowheads)
and was accompanied by reduced acetylation of α-tubulin
(Figure 3H). Since stable, acetylated MTs are less sensitive to
depolymerization, the correlation of β-III- and acetylated α-
tubulin was used as a measure for MT integrity. This readout
revealed a time-dependent decrease in MT integrity (Figure 3I).
At the functional level, nocodazole destabilization induced a
progressive loss of active neurons (Figure 3J) and synchronous
calcium bursting behavior (Figures 3K,L).
These results indicate that hyperstabilization as well as
depolymerization of neuronal MTs impair morphofunctional
connectivity in primary culture. Therefore, we conclude that tight
regulation of MT stability is important for maintaining synaptic
connectivity in neuronal networks.
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FIGURE 3 | Nocodazole-induced MT depolymerization adversely affects morphofunctional neuronal connectivity. (A) Chronic (4–7 DIV) treatment with the
MT-depolymerizing drug nocodazole did not induce significant toxicity, measured as the percentage of PI-positive nuclei, up to a concentration of 100 nM (nb = 2, nw
= 4). (B,C) Quantification of neurite- and synapse density revealed a reduction in both parameters after exposure to 100 nM nocodazole. At a concentration of 10 nM,
the neurite density was reduced while the synapse density was largely unaffected (nb = 2, nw = 4). (D–F) Functional connectivity was studied by means of live cell
calcium imaging (nb = 2, nw = 4). The percentage of active neurons, frequency of synchronous bursts and burst correlation gradually decreased until statistically
(Continued)
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FIGURE 3 | Continued
significant at a concentration of 100 nM nocodazole. (G) β-III-tubulin staining after acute nocodazole treatment (7 DIV, 2/4/8 h treatment), revealed progressive
thinning of neurites and the appearance of tubulin patches (arrowheads). (H) Measurement of the intensity ratio of acetylated α-/β-III-tubulin showed a time-dependent
reduction in tubulin acetylation, indicative of MT destabilization (nb = 2, nw = 4). (I) Colocalization of β-III- and acetylated α-tubulin was measured to quantify MT
integrity with high sensitivity and showed progressive MT depolymerization (nb = 2, nw = 4). (J) Calcium imaging revealed a significant reduction in the percentage of
active neurons, 8 h after nocodazole addition. (K,L) Synchronized activity was impaired in a time-dependent manner, with almost complete loss of synchrony after 8 h
(nb = 3, nw = 4). *p < 0.05; **p < 0.005.
Nocodazole-Induced Connectivity Defects
Can Be Rescued by MT Stabilizers
Next, we sought to investigate whether chemically induced MT
depolymerization could be rescued with MT stabilizers. Neurons
were exposed to nocodzaole for 4 h. During the last 2 h of
these 4 h, paclitaxel was added (Figure 4A). Epothilone D, a
MT stabilizer with similar action but better BBB penetration
than taxanes (Brunden et al., 2011), was included here to
broaden the potential translational value of these experiments.
DMSO was used as a control, both upon nocodazole and
MT stabilizer treatment. As shown in previous experiments,
nocodazole treatment for 4 h significantly reduced the Pearson’s
correlation coefficient (PCC, Figures 4B,D), pointing to a
morphological breakdown of MTs. Conversely, addition of
MT stabilizers 2 h after nocodazole incubation, (partly)
rescued the nocodazole-induced PCC decrease (Figures 4B,D),
while a decrease in neurite density, measured as the β-III-
tubulin area, remained evident (Figure 4C). This combined
treatment correlated with an improvement in functional
connectivity, as evidenced by an increase in the percentage
of active neurons (Figure 4E), synchronous bursting frequency
(Figure 4F) and burst correlation (Figure 4G), in comparison
with the nocodazole treatment alone.
These results show that chemically induced defects in MT-
stability are reversible, at least in short-term experiments.
MAPT Overexpression Induces
Connectivity Defects That Correlate with
MT Binding Affinity
To further study the role of MT dynamics in neuronal
connectivity, we adopted a model for overexpression and
intracellular aggregation of the MT-associated protein Tau
in primary neurons (Figure 5A) (Guo and Lee, 2013). At 3
DIV, neurons were infected with AAV particles to trigger
overexpression of human normal MAPT or mutant MAPT-
P301L, resulting in overproduction of normal Tau or mutant
Tau-P301L protein, respectively. The gene encoding the latter
harbors a point mutation in the fourth MT-binding domain that
decreases the affinity for MTs (Hong et al., 1998; Dayanandan
et al., 1999). At 6 DIV part of these cultures were exposed
to K18 fibrils to seed intracellular aggregation of Tau. Such
fibrils consist of truncated P301L-4R-Tau, rich in β-sheets
that induce aggregation (Siddiqua and Margittai, 2010). At 15
DIV, AT8 immunostaining showed higher Tau phosphorylation
for both overexpression models, irrespective of K18 seeding,
suggesting that the increased phosphorylation status is not
sufficient to induce aggregation (Figure 5C). Intracellular Tau
aggregates appeared as pFTAA-positive structures only in
cells overexpressing MAPT-P301L and treated with K18 fibrils
(Figures 5B,D; Supplemental Video 1). Tau aggregation was
not observed in cultures that did not receive K18 fibrils or
upon normal MAPT overexpression, indicating that the P301L
gene product had an increased tendency to aggregate. At this
MOI (100), overexpression of cytosolic eGFP (used as control)
did not induce cytotoxicity, nor did it change the functional
connectivity (Supplemental Figure 1). However, cytotoxicity
measurements at different DIVs revealed the toxic effect of
MAPT overexpression at later time points. This was not observed
for MAPT-P301L overexpression (Figure 5E). K18 seeding did
not exacerbate cytotoxicity in either model. Upon MAPT
overexpression, a reduction in neurite density was observed for
all time points (Figure 5F). A plausibly compensatory increase
in synapse density occurred only at 9 and 12 DIV (Figure 5G).
Functionally,MAPT overexpression impaired neuronal network
activity, as confirmed by a decreased percentage of active neurons
(Figure 5H) and a reduction in the frequency of synchronous
bursts (Figure 5I). Corresponding to the cytotoxicity and
morphology measurements, MAPT overexpression had a more
profound effect on the percentage of active neurons than
MAPT-P301L overexpression, and seeding with K18 fibrils
did not exacerbate the connectivity impairment. In line with
the observations that were made for paclitaxel, none of the
treatments consistently altered the burst correlation (Figure 5J).
As such, the activity remained synchronous, albeit depressed
in frequency. Remarkably, the presence of Tau aggregates did
not affect the neuron’s ability to burst in synchrony with
the surrounding network of unaffected neurons (Supplemental
Figure 2).
These results show that MAPT overexpression induced
more severe connectivity defects than MAPT-P301L, which
corresponds with their respective binding affinity to MTs.
They also demonstrate that K18 seeding does not exacerbate
connectivity impairment, not even when intracellular Tau
aggregation is induced.
MT Dynamics Are Differentially Altered by
Tau and Tau-P301L
To directly investigate MT dynamics in detail, the velocity of
EB3-RFP comets, located at the MT plus ends, was quantified
at 10 DIV (Figure 6A). To keep consistency with previous
results and work in optimally interconnected networks, a low-
efficiency transfection protocol was used to sparsely label isolated
neurons within dense networks, rather than to e.g., isolate axons
in microchannel-based cultivation systems (Kilinc et al., 2015).
Paclitaxel treatment, which was used as a positive control, showed
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FIGURE 4 | Nocodazole-induced impairment of neuronal network connectivity can be rescued by MT stabilizers. (A) Treatment scheme. The cultures were exposed to
nocodazole for 4 h. During the last 2 of these 4 h, the MT stabilizers paclitaxel or epothilone D were added. DMSO was added as control. (B) A decreased correlation
between β-III- and acetylated α-tubulin, a marker for the more stable population of MTs, was detected after 4 h nocodazole treatment, consistent with the staining in
(D). This phenotype could be partially rescued by adding paclitaxel (100 nM) and epothilone D (100 nM) during the last 2 h of nocodazole treatment (nb = 3, nw = 4).
(C) Measurement of the β-III-tubulin area did not reveal any rescue of the nocodazole-induced reduction (nb = 3, nw = 4). (D) Immunostaining for β-III- and acetylated
(Continued)
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FIGURE 4 | Continued
α-tubulin showed that nocodazole treatment (4 h) induced the formation of β-III-positive/acetylated α-negative tubulin patches (arrowheads; 7 DIV). This effect was
rescued by adding the MT-stabilizing drugs paclitaxel or epothilone D during the last 2 h of nocodazole treatment. (E) A decreased percentage of neurons showed
calcium activity after nocodazole treatment. This impairment could be rescued by subsequent MT re-stabilization (nb = 3, nw = 4). (F,G) While nocodazole treatment
alone impaired the synchronous network activity, combination treatment with MT stabilizers showed similar functional connectivity to DMSO-treated controls (nb = 3,
nw = 4). *p < 0.05; **p < 0.005.
a decrease in EB3 velocity for chronic (10 nM, 3–10 DIV)
and acute (100 nM, 4 h) exposure (Figures 6A,B). Similar to
paclitaxel, MAPT overexpression dose-dependently decreased
EB3 velocity; an effect that was not observed upon MAPT-
P301L overexpression. Nocodazole treatment (1 µM, 4 h) caused
all EB3 comets to vanish, plausibly because they disengaged
from depolymerizing MT (Supplemental Video 2). Paclitaxel-
treated neurons or neurons overexpressing MAPT or MAPT-
P301L did not show any difference in correlation between β-III-
and acetylated α-tubulin, suggesting no alteration in MT stability
(Figure 6C). However, co-exposure of the neurons to nocodazole
(1 µm, 4 h, 10 DIV), revealed significant differences, indicating
differential sensitivity to depolymerization: overexpression of
MAPT, much like pre-treatment with paclitaxel, partly protected
against nocodazole-induced depolymerization, whereas MAPT-
P301L overexpression did not.
Together, these data suggest that overexpression of MAPT
induces a paclitaxel-like stabilization of neuronal MT and has
an adjoined impact on neuronal connectivity (Figure 5), while
MAPT-P301L overexpression does far less.
Subtle MT Depolymerization Neither
Prevents Nor Rescues Tau-Induced
Connectivity Defects
Since MAPT overexpression was found to induce paclitaxel-
like stabilization of neuronal MTs, we tested the potential of
long-term nocodazole treatment to prevent (treatment at 0
+ 4 DIV) or rescue (from 4 DIV onwards) the associated
connectivity defects (Figure 7A). Morphological interrogation
showed a tendency toward decreased neurite density in neurons
overexpressing MAPT but not MAPT-P301L (Figure 7B). Long-
term preventive or rescue treatment with a low nocodazole
concentration did not alleviate this phenotype, but rather
aggravated it. Synapse density was not affected in any condition
(Figure 7C). Calcium imaging showed a reduction in the
percentage of active neurons for MAPT overexpression only.
But, this defect was not improved by nocodazole (pre-
)treatment (Figure 7D). Corresponding to this observation, a
tendency toward decreased synchronized activity upon MAPT
overexpression was seen that was less pronounced for MAPT-
P301L overexpression (Figures 7E,F). Also in these parameters,
no beneficial effect of nocodazole was detected.
These data show that Tau-induced connectivity defects cannot
be rescued by nocodazole treatment.
DISCUSSION
Neuronal MTs support many functions that are important
for synaptic connectivity, such as neurite outgrowth, polarized
cargo transport and local signaling at the synapse (Gardiner
et al., 2011; Matamoros and Baas, 2016). Using functionally
connected primary neurons, we showed that positive (paclitaxel)
as well as negative (nocodazole) pharmacological modulation
of MT stability impairs morphofunctional connectivity. It was
shown before that paclitaxel inhibits both the shortening
and growth rates, and hence the dynamic instability of MTs
in cancer cells (Yvon et al., 1999). We now confirmed
a decreased velocity of EB3-RFP comets and an enhanced
protection against depolymerization in primary hippocampal
neurons. Paclitaxel-treated cultures also showed impaired
morphofunctional connectivity, which was already apparent
by calcium imaging, at concentrations as low as 1 nM. In
addition to MT hyperstabilization by paclitaxel, long- and short-
term nocodazole treatment also impaired morphofunctional
connectivity in these primary hippocampal neurons. Short-
term treatment induced the disappearance of EB3-RFP comets,
thinning of neurites and the appearance of tubulin patches in
the vicinity of neurites, recapitulating the hallmarks of MT
depolymerization. Perturbation of synchronous calcium bursting
by nocodazole was detected after 4 h, while immunostaining
for β-III-tubulin showed breakdown of MTs already at earlier
time points. Although more research is needed to uncover the
exact reason for this time lag, one could hypothesize that the
synapse is self-sufficient for a limited amount of time as a result
of synaptic vesicle recycling. In support of this hypothesis, super-
resolution microscopy experiments revealed that nocodazole
affects the transport of synaptic vesicles exclusively in neurites
but not in synapses (Maschi and Klyachko, 2015). From this
set of pharmacology experiments, we concluded that strict
regulation of MT dynamics is essential for maintaining synaptic
connectivity in primary hippocampal cultures.
We showed that paclitaxel pre-treatment reduced
morphological MT breakdown, and subsequent treatment
rescued nocodazole-induced connectivity defects. Furthermore,
we successfully included epothilone D in the nocodazole rescue
experiments. This compound stabilizes MT in a paclitaxel-like
fashion (Alberti, 2013), but has better blood-brain-barrier
penetration, making it a more attractive therapeutic compound
for the CNS (Brunden et al., 2011). Since we expect the
differences between paclitaxel and epothilone D to only become
evident in in vivo experiments, we did not fully characterize the
effect of epothilone D onmorphofunctional connectivity in vitro.
Nevertheless, the fact that nocodazole-induced connectivity
defects could be rescued by epothilone D broadens the potential
translational value of our findings. It remains, however, difficult
to conclude whether MTs represent druggable targets in
disorders characterized by impaired neuronal connectivity,
since we also showed that MT hyperstabilization (Figure 2) and
depolymerization (Figure 3) compromised morphofunctional
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FIGURE 5 | Overexpression of MAPT and MAPT-P301L induces phenotypically distinct defects in neuronal network connectivity. (A) Schematic representation of the
treatment protocol. At 6 DIV, pre-formed Tau fibrils (K18) were added to half of the cultures as seeds for Tau aggregation. (B) Fluorescent labeling of 15 DIV cultures
with an AT8 antibody for hyperphosphorylated Tau and pFTAA for fibrillar Tau. (C,D) MAPT and MAPT-P301L overexpression induced Tau hyperphosphorylation, but
intracellular Tau aggregates were only detected upon MAPT-P301L overexpression and seeding with K18 fibrils (nb = 2; nw = 3). (E) Cytotoxicity, measured as the
percentage of PI-positive nuclei, was detected at later time points and was more pronounced for MAPT than for MAPT-P301L overexpression, while K18 seeding did
(Continued)
Frontiers in Cellular Neuroscience | www.frontiersin.org 11 June 2017 | Volume 11 | Article 173
Verstraelen et al. MT Stability and Neuronal Connectivity
FIGURE 5 | Continued
not exacerbate cell death (nb = 2, nw = 3). (F,G) Quantification of neurite- and synapse density after immunostaining for MAP2 and synaptophysin. While neurite
density was decreased upon MAPT overexpression on all time points, a—plausibly compensatory—increase in synapse density was only seen at 9 and 12 DIV (nb =
2, nw = 3). (H) Live cell calcium imaging showed a reduction in the percentage of active neurons that was more pronounced for MAPT than for MAPT-P301L
overexpression (nb = 2, nw = 6). (I) The frequency of synchronous bursts was decreased upon MAPT and MAPT-P301L overexpression. (J) The synchronicity of
bursting was not consistently affected by any treatment. Addition of K18 fibrils did not alter the network activity. *p < 0.05; **p < 0.005.
FIGURE 6 | MT dynamics are differentially altered by MAPT and MAPT-P301L overexpression. (A) One-minute recordings (0.5 frames/min) of EB3-RFP
overexpressing neurons were made to directly visualize the dynamics of MTs at 10 DIV. After selection of a stretch of at least 20 µm, a moving EB3 comet
(arrowheads) can be discerned. Kymographs of an untreated vs. a paclitaxel treated neuron clearly show the difference in velocity, measured as the slope of the EB3
track. (B) Quantification showed reduced EB3 velocity in paclitaxel-treated neurons, which was less pronounced for long-term (10 nM, 3–10 DIV) than for short-term
(100 nM, 4 h) treatment. Neurons overexpressing MAPT displayed a similar and dose-dependent reduction, which was absent upon MAPT-P301L overexpression
(3–10 DIV, nb = 2, nw = 3, ≥ 7 segments/well). (C) MT integrity was quantified by measuring the colocalization of β-III- and acetylated α-tubulin. Though no difference
in MT integrity was seen under basal conditions, paclitaxel treatment and MAPT overexpression protected against nocodazole-induced MT depolymerization, while
MAPT-P301L overexpression did not (3–10 DIV; nb = 2, nw = 5). *p < 0.05; **p < 0.005.
connectivity. As such, it might prove difficult to determine a safe
dose and timing scheme for such treatment.
To further confirm the hypothesis that MT dynamics
determine the level of synaptic connectivity, we switched to
a disease model relevant for tauopathies. In physiological
conditions, the MT-associated protein Tau stabilizes MTs by
binding to the interface between tubulin heterodimers (Kadavath
et al., 2015). We found that overexpression of MAPT in
hippocampal neurons led to cytotoxicity and impaired network
activity. Given the observation that MAPT overexpressing
neurons, just like paclitaxel-treated neurons, were more resistant
to nocodazole-induced depolymerization and displayed lower
EB3 velocity, we conclude that the negative impact on synaptic
connectivity is at least partly the result of MT hyperstabilization.
This was further confirmed by the observation thatMAPT-P301L
overexpression evoked less pronounced connectivity defects.
Several groups previously reported that Tau-P301L displayed
reduced affinity for MTs in biochemical assays (Hong et al.,
1998; Barghorn et al., 2000; Fischer et al., 2007) or in cell
lines (Dayanandan et al., 1999; DeTure et al., 2000; Lu et al.,
2000). Although the above-mentioned observations strongly
suggest a link between Tau-induced MT hyperstabilization and
connectivity impairment, mild nocodazole depolymerization did
not prevent nor rescue such defects. Although we cannot exclude
that other treatment schemes might reveal such rescue, the
current data suggest that MT stability is not the sole target of
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FIGURE 7 | Subtle MT depolymerization neither prevents nor rescues Tau-induced connectivity defects. (A) Schematic representation of the treatment protocol.
Nocodazole was added at 0+4 or 4 DIV. (B) Quantification of neurite outgrowth after MAP2 immunostaining showed a tendency toward reduced neurite density upon
MAPT but not MAPT-P301L overexpression. Chronic nocodazole (pre-)treatment did not rescue but rather aggravated this defect (nb = 2, nw = 3). (C) Quantification
of synaptophysin spots showed that synapse density was not affected by MAPT overexpression (nb = 2, nw = 3). (D) Live cell calcium imaging at 10 DIV showed a
reduction in the percentage of active neurons upon MAPT overexpression that was not rescued by nocodazole (pre-)treatment (nb = 2, nw = 3). (E,F) A slight, but
non-significant, reduction in the synchronous bursting frequency and burst correlation was detected upon MAPT overexpression. This reduction was less pronounced
in the case of MAPT-P301L overexpression and could not be rescued by chronic nocodazole treatment (nb = 2, nw = 3). *p < 0.05; **p < 0.005.
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MAPT overexpression. In line with this, next to its MT-binding
capacity, Tau has been shown to modulate chromatin relaxation,
translation initiation and mitochondrial function (Eckert et al.,
2014; Frost et al., 2014;Meier et al., 2016). Nevertheless, a broader
range of nocodazole concentrations and treatment times should
be tested to fully support this conclusion.
The amino acid residues responsible for MT binding are
also essential for the pathological aggregation of Tau (Mukrasch
et al., 2005; Kadavath et al., 2015). We adopted an in vitro
model based on the induction of aggregation by preformed K18
Tau fibrils (Guo and Lee, 2013). Consistent with literature, we
found that only MAPT-P301L but not MAPT overexpressing
neurons showed formation of intracellular Tau aggregates
after K18 seeding (Guo and Lee, 2013). A combination of
conformational changes and reduced MT binding are believed
to underlie this property (Barghorn et al., 2000; von Bergen
et al., 2001; Terwel et al., 2005). Surprisingly, segregated analysis
of calcium signals in MAPT-P301L overexpressing neurons
with and without intracellular Tau aggregates did not expose
an aggravated phenotype in the former. One explanation for
this could be that synaptotoxicity results from oligomeric
hyperphosphorylated Tau, rather than from insoluble tangles
(Hoover et al., 2010; Cowan andMudher, 2013; Guerrero-Munoz
et al., 2015; Kruger and Mandelkow, 2016). The sudden exposure
to pre-formed Tau fibrils may bypass the slow oligomerization
phase that normally precedes Tau aggregation (Guo and Lee,
2014). Alternatively, the background expression levels of normal
MAPT may mask MAPT-P301L-dependent effects. The recent
advent of CRISPR/Cas9 genome editing technology (Ran et al.,
2013)may lead to the generation of more accurate mousemodels.
Suchmodels might disclose subtle phenotypic alterations that are
more difficult to detect in the overexpressionmodel that was used
in this study.
Like every in vitro model, the neuronal networks that
were used in this study have obvious limitations. The cells
are grown in 2D, they lack the different cell types and
specific wiring pattern as seen in the hippocampus, and they
are devoid of external input. The results obtained with this
system should therefore be validated in animal models and
eventually in men. From a translational perspective, chronic
administration of low doses of epothilone D was found to
improve neuropathology and cognitive performance in several
tauopathy mice (Brunden et al., 2010; Barten et al., 2012; Zhang
et al., 2012). Similar results were obtained in C. elegans and
Aplysia (Shemesh and Spira, 2011; Erez et al., 2014; Miyasaka
et al., 2016). Nevertheless, one phase I clinical trial to assess
the safety, tolerability and effect of low doses of epothilone D
in subjects with mild AD did not proceed to phase II (http://
www.clinicaltrials.gov/ct/show/NCT01492374). The results of
this specific trial remained unpublished, but in general, gaps
in the fundamental knowledge are causing the high failure
rates in AD-related clinical trials. In light of this, the current
study contributes to the basic understanding of the role of MT
stability in neuronal connectivity. We used primary hippocampal
neurons that, in contrast to immortal neuronal cell lines such
as neuroblastoma cells, retain several in vivo properties like
spontaneous neurite outgrowth, synapse formation and, most
importantly, synchronized electrical activity. The translational
value of this model may even be further improved by switching
to a fully humanized system. It was recently shown that human
iPSC-derived neurons develop synchronized network activity
and can be interrogated for morphofunctional connectivity
(Kuijlaars et al., 2016). Though current reprogramming protocols
are tedious and time-consuming as compared to cultivating
mouse primary neurons, they can even be derived from patients
with sporadic forms of the disease (Armijo et al., 2017) and can
be combined with gene editing approaches (Paquet et al., 2016).
In conclusion, we have used an in vitro approach to expose
the relevance of MT stability in maintaining neuronal network
connectivity. Despite proof for reversible pharmacological
tuning, a subtle balance and dose and time dependency currently
hamper fast translational progress for this potential therapeutic
target.
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